# An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults

> **NCT01178099** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 26 (actual)

## Conditions studied

- Anemia, Sickle Cell

## Interventions

- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01178099
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01178099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01178099, "An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01178099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*